文献速递血栓与止血

B型血与否?重大创伤休克患者中ABO血型与早期死亡率及器官功能障碍的关联

Group B or not group B? An association between ABO, early mortality, and organ dysfunction in major trauma patients with shock.
PubMed 文献 · J Thromb Haemost · 2023-12-07

该研究在英國一家重大创伤中心的前瞻性观察队列中,分析1119例严重创伤成人患者的ABO血型与入院凝血谱、死亡率及免疫介导并发症的关系。总体死亡率无差异;休克亚组中B型血患者24小时死亡率低于非B型(7% vs 16%,aOR 0.19,P=0.030),但侵入性通气、肾脏替代治疗及感染趋势增加,且凝血因子水平更高。

要点

  • 1119例创伤患者中ABO血型总体死亡率无差异。
  • 休克亚组B型血24小时死亡率7% vs 非B型16%(aOR 0.19,P=0.030)。
  • 休克亚组B型血侵入性通气aOR 3.34、肾脏替代治疗aOR 2.55,感染aOR 1.85(P=0.067)。

核心结论

  • 在受限于单时间点采样和创伤出血休克亚组分析的观察性研究中,B型血患者止血能力增强,与早期生存相关,但免疫介导并发症风险增加。

研究设计与样本

  • 英国一家重大创伤中心持续性观察队列中纳入的严重创伤成人患者,进行单变量和多变量分析。
  • 在休克亚组中对旋转血栓弹力图参数和凝血生物标志物进行探索性分析。

主要发现

  • 1119例创伤患者中ABO血型组间死亡率无差异。
  • 休克患者中B型血 vs 非B型血24小时死亡率为7% vs 16%(aOR 0.19;P=0.030)。
  • 休克患者中B型血侵入性通气aOR 3.34(P=0.033),肾脏替代治疗aOR 2.55(P=0.037),感染aOR 1.85(P=0.067)。
  • 休克患者中B型血 vs 非B型血纤维蛋白原高40%,凝血因子VIII高65%,凝血因子IX高36%,凝血因子XIII高20%,血管性血友病因子高19%。

局限性

  • 原文指出该观察性研究受限于单时间点采样和创伤出血休克的亚组分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: ABO blood group alters coagulation profiles in the general population and may influence outcomes after trauma. The relationship between trauma-induced coagulopathy, severe injury with hemorrhagic shock, and survival with respect to ABO group is unknown. OBJECTIVES: In severe hemorrhagic trauma, we aimed to characterize the association of ABO group with admission coagulation profiles, mortality, and immune-mediated complications. METHODS: Clinical and laboratory variables were examined from severely injured adult patients enrolled in a perpetual observational cohort study at a UK Major Trauma Center. Univariate and multivariate analyses were performed to determine differences in clinical outcomes (mortality, organ dysfunction, and critical care support). In a shock subgroup, we performed an exploratory analysis of rotational thromboelastometry parameters and coagulation biomarkers. RESULTS: In 1119 trauma patients, we found no difference in mortality between ABO groups. In patients with shock, 24-hour mortality was significantly lower in group B vs non-B groups (7% vs 16%, adjusted odds ratio [aOR], 0.19; P = .030), but there were increased rates of invasive ventilation (aOR, 3.34; P = .033), renal replacement therapy (aOR, 2.55; P = .037), and a trend for infection (aOR, 1.85; P = .067). Comparing patients with shock, group B vs non-B patients had 40% higher fibrinogen, 65% higher factor (F) VIII, 36% higher FIX, 20% higher FXIII, and 19% higher von Willebrand factor. CONCLUSION: In this observational study limited by single time-point sampling and subgroup analysis of trauma hemorrhage with shock, group B patients have enhanced hemostatic capability associated with early survival but with increased risk of immune-mediated complications.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Schofield H, Lindsay C, Brohi K, et al. Group B or not group B? An association between ABO, early mortality, and organ dysfunction in major trauma patients with shock. J Thromb Haemost. 2023. PMID: 38070741. doi:10.1016/j.jtha.2023.11.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。